vs

Side-by-side financial comparison of Definitive Healthcare Corp. (DH) and NATURAL ALTERNATIVES INTERNATIONAL INC (NAII). Click either name above to swap in a different company.

Definitive Healthcare Corp. is the larger business by last-quarter revenue ($61.5M vs $34.8M, roughly 1.8× NATURAL ALTERNATIVES INTERNATIONAL INC). NATURAL ALTERNATIVES INTERNATIONAL INC runs the higher net margin — -7.3% vs -15.1%, a 7.8% gap on every dollar of revenue. On growth, NATURAL ALTERNATIVES INTERNATIONAL INC posted the faster year-over-year revenue change (2.1% vs -1.2%). Definitive Healthcare Corp. produced more free cash flow last quarter ($-1.7M vs $-7.3M). Over the past eight quarters, NATURAL ALTERNATIVES INTERNATIONAL INC's revenue compounded faster (17.7% CAGR vs -1.5%).

Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.

Natural Alternatives International, Inc. (NAI) is an American company based in Carlsbad, California which manufactures nutritional supplements such as Juice Plus. NAI was founded in 1980 by Mark A. LeDoux, and had 241 employees in 2007. NAI's manufacturing facilities are located in Vista, California, Switzerland and Japan.

DH vs NAII — Head-to-Head

Bigger by revenue
DH
DH
1.8× larger
DH
$61.5M
$34.8M
NAII
Growing faster (revenue YoY)
NAII
NAII
+3.3% gap
NAII
2.1%
-1.2%
DH
Higher net margin
NAII
NAII
7.8% more per $
NAII
-7.3%
-15.1%
DH
More free cash flow
DH
DH
$5.5M more FCF
DH
$-1.7M
$-7.3M
NAII
Faster 2-yr revenue CAGR
NAII
NAII
Annualised
NAII
17.7%
-1.5%
DH

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
DH
DH
NAII
NAII
Revenue
$61.5M
$34.8M
Net Profit
$-9.3M
$-2.6M
Gross Margin
76.2%
7.2%
Operating Margin
-43.3%
-5.3%
Net Margin
-15.1%
-7.3%
Revenue YoY
-1.2%
2.1%
Net Profit YoY
84.2%
-16.5%
EPS (diluted)
$-0.14
$-0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DH
DH
NAII
NAII
Q4 25
$61.5M
$34.8M
Q3 25
$60.0M
$37.7M
Q2 25
$60.8M
$33.9M
Q1 25
$59.2M
$28.8M
Q4 24
$62.3M
$34.1M
Q3 24
$62.7M
$33.1M
Q2 24
$63.7M
$29.5M
Q1 24
$63.5M
$25.1M
Net Profit
DH
DH
NAII
NAII
Q4 25
$-9.3M
$-2.6M
Q3 25
$-14.8M
$-291.0K
Q2 25
$-7.6M
$-7.2M
Q1 25
$-107.2M
$-2.2M
Q4 24
$-59.1M
$-2.2M
Q3 24
$-130.9M
$-2.0M
Q2 24
$-213.6M
$-1.9M
Q1 24
$-9.5M
$-1.6M
Gross Margin
DH
DH
NAII
NAII
Q4 25
76.2%
7.2%
Q3 25
76.6%
11.7%
Q2 25
76.7%
10.4%
Q1 25
73.9%
6.3%
Q4 24
76.4%
4.9%
Q3 24
78.2%
6.8%
Q2 24
79.2%
4.8%
Q1 24
79.4%
7.6%
Operating Margin
DH
DH
NAII
NAII
Q4 25
-43.3%
-5.3%
Q3 25
-14.5%
0.8%
Q2 25
-6.9%
-5.7%
Q1 25
-312.2%
-7.3%
Q4 24
-159.8%
-8.2%
Q3 24
-359.5%
-5.5%
Q2 24
-579.9%
-8.6%
Q1 24
-25.6%
-7.8%
Net Margin
DH
DH
NAII
NAII
Q4 25
-15.1%
-7.3%
Q3 25
-24.7%
-0.8%
Q2 25
-12.4%
-21.3%
Q1 25
-181.2%
-7.6%
Q4 24
-94.8%
-6.4%
Q3 24
-208.8%
-6.0%
Q2 24
-335.2%
-6.4%
Q1 24
-15.0%
-6.3%
EPS (diluted)
DH
DH
NAII
NAII
Q4 25
$-0.14
$-0.42
Q3 25
$-0.14
$-0.05
Q2 25
$-0.07
$-1.21
Q1 25
$-0.95
$-0.37
Q4 24
$-0.53
$-0.37
Q3 24
$-1.12
$-0.33
Q2 24
$-1.81
$-0.32
Q1 24
$-0.08
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DH
DH
NAII
NAII
Cash + ST InvestmentsLiquidity on hand
$180.9M
$3.8M
Total DebtLower is stronger
$156.1M
Stockholders' EquityBook value
$379.0M
$67.0M
Total Assets
$735.5M
$153.3M
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DH
DH
NAII
NAII
Q4 25
$180.9M
$3.8M
Q3 25
$185.9M
$7.7M
Q2 25
$184.2M
$12.3M
Q1 25
$200.7M
$10.6M
Q4 24
$290.2M
$8.7M
Q3 24
$305.4M
$10.2M
Q2 24
$296.5M
$12.0M
Q1 24
$295.2M
$12.4M
Total Debt
DH
DH
NAII
NAII
Q4 25
$156.1M
Q3 25
$158.2M
Q2 25
$160.3M
Q1 25
$162.4M
Q4 24
$229.4M
Q3 24
$232.7M
Q2 24
$236.0M
Q1 24
$239.3M
Stockholders' Equity
DH
DH
NAII
NAII
Q4 25
$379.0M
$67.0M
Q3 25
$389.7M
$69.0M
Q2 25
$411.2M
$68.4M
Q1 25
$435.9M
$76.6M
Q4 24
$607.2M
$79.1M
Q3 24
$695.6M
$80.2M
Q2 24
$886.3M
$82.6M
Q1 24
$1.2B
$84.1M
Total Assets
DH
DH
NAII
NAII
Q4 25
$735.5M
$153.3M
Q3 25
$755.5M
$156.9M
Q2 25
$770.1M
$151.9M
Q1 25
$808.7M
$154.9M
Q4 24
$1.1B
$156.1M
Q3 24
$1.2B
$161.3M
Q2 24
$1.4B
$162.3M
Q1 24
$1.8B
$153.2M
Debt / Equity
DH
DH
NAII
NAII
Q4 25
0.41×
Q3 25
0.41×
Q2 25
0.39×
Q1 25
0.37×
Q4 24
0.38×
Q3 24
0.33×
Q2 24
0.27×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DH
DH
NAII
NAII
Operating Cash FlowLast quarter
$2.7M
$-6.3M
Free Cash FlowOCF − Capex
$-1.7M
$-7.3M
FCF MarginFCF / Revenue
-2.8%
-20.9%
Capex IntensityCapex / Revenue
7.2%
2.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$37.1M
$-5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DH
DH
NAII
NAII
Q4 25
$2.7M
$-6.3M
Q3 25
$15.7M
$-4.0M
Q2 25
$9.3M
$3.3M
Q1 25
$26.1M
$6.0M
Q4 24
$8.1M
$37.0K
Q3 24
$19.4M
$-3.4M
Q2 24
$14.0M
$-2.7M
Q1 24
$16.6M
$-3.6M
Free Cash Flow
DH
DH
NAII
NAII
Q4 25
$-1.7M
$-7.3M
Q3 25
$13.4M
$-5.1M
Q2 25
$7.0M
$1.9M
Q1 25
$18.4M
$5.2M
Q4 24
$-2.8M
$-1.0M
Q3 24
$18.7M
$-3.7M
Q2 24
$13.6M
$-3.8M
Q1 24
$16.3M
$-3.9M
FCF Margin
DH
DH
NAII
NAII
Q4 25
-2.8%
-20.9%
Q3 25
22.3%
-13.4%
Q2 25
11.5%
5.6%
Q1 25
31.0%
18.0%
Q4 24
-4.4%
-3.0%
Q3 24
29.8%
-11.3%
Q2 24
21.4%
-12.7%
Q1 24
25.7%
-15.5%
Capex Intensity
DH
DH
NAII
NAII
Q4 25
7.2%
2.7%
Q3 25
3.8%
2.7%
Q2 25
3.8%
4.3%
Q1 25
13.0%
2.8%
Q4 24
17.5%
3.1%
Q3 24
1.2%
0.9%
Q2 24
0.6%
3.5%
Q1 24
0.4%
1.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DH
DH

Subscription Services$58.5M95%
Professional Services$3.0M5%

NAII
NAII

Private Label Contract Manufacturing$32.8M94%
Patent And Trademark Licensing$2.0M6%

Related Comparisons